The first regulatory submission for a CRISPR-based therapy has been validated by the European Medicines Agency, to treat sickle cell disease and transfusion-dependent beta thalassemia.

Find a Job – PostAc
PostAc® makes the hidden industry research-intensive job market visible for research degree graduates.






